January 16, 2018

Over the last year the Cabinet has engaged a variety of stakeholders including industry experts, government leaders, researchers, consumers, providers, health plans and advocates, to help the identify a set of detailed recommendations to address pharmaceutical costs. The draft report of recommendations represents the combined efforts of various workgroups and Cabinet discussion. After initial review and consideration of the recommendations of each workgroup, the Cabinet directed the workgroup chairs to collaborate to prioritize the recommendations and combine them into one report to present to the public for comment. Recommendations are organized into two categories; those that require legislation and those that can be implemented using existing administrative authority. After public feedback has been collected, the Cabinet will again consider the recommendations at its January 16, 2018 meeting and may change and reprioritize the list prior to sending a final report to the Governor and the legislature for consideration. Written public comment will be accepted until February 6, 2018 at 4:30 p.m. Comments should be sent to Victoria Veltri, Chief Health Policy Advisor, at victoria.veltri@ct.gov. All comments will be posted on the Cabinet website with the January 16th meeting materials.